Evaluating the use of circulating tumor DNA (ctDNA) in patients with urothelial cancer in the context of FGFR-targeted therapy.

被引：0
|
作者：
Schonlau, Elena
Mueller, David Christian
Vandekerkhove, Gillian
Murtha, Andrew
Bacon, Jack V. W.
Wells, Connor
Rostin, Kimia
Parimi, Sunil
Noonan, Krista
Basappa, Naveen S.
Ko, Jenny J.
Finch, Daygen L.
Alimohamed, Nimira S.
Bismar, Tarek A.
Nappi, Lucia
Annala, Matti
Bernales, Cecily Q.
Chi, Kim N.
Wyatt, Alexander William
Eigl, Bernhard J.
机构：
[1] BC Canc Vancouver Ctr, Dept Med Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
[3] BC Canc Surrey Ctr, Dept Med Oncol, Surrey, BC, Canada
[4] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada
[5] BC Canc Abbotsford Ctr, Dept Med Oncol, Abbotsford, BC, Canada
[6] BC Canc Kelowna Ctr, Dept Med Oncol, Kelowna, BC, Canada
[7] Tom Baker Canc Clin, Dept Med Oncol, Calgary, AB, Canada
[8] Tampere Univ, Tampere, Finland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4577
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with advanced urothelial cancer
    Miron, B.
    Li, G.
    Clark, A.
    Pasquina, L.
    Graf, R. P.
    Oxnard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1220 - S1220
  • [2] Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of cancer therapy.
    Gouda, Mohamed Alaa
    Huang, Helen J.
    Piha-Paul, Sarina Anne
    Call, S. Greg
    Karp, Daniel D.
    Fu, Siqing
    Naing, Aung
    Subbiah, Vivek
    Pant, Shubham
    Tsimberidou, Apostolia Maria
    Hong, David S.
    Ahnert, Jordi Rodon
    Meric-Bernstam, Funda
    Janku, Filip
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
    Khatami F.
    Tavangar S.M.
    Journal of Diabetes & Metabolic Disorders, 2018, 17 (1): : 19 - 30
  • [4] Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
    Duffy, Michael J.
    Crown, John
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [5] REAL WORLD USE OF CIRCULATING TUMOR DNA (CTDNA) IN COLORECTAL CANCER (CRC): A TARGETED LITERATURE REVIEW (TLR)
    Jones, G. S.
    Bagga, S.
    Sood, P.
    Hariprasad, E.
    Mangla, B.
    Soni, P.
    Sharma, N.
    Jain, A.
    Goswami, A.
    Singh, P.
    Kumar, S.
    Kothari, S.
    VALUE IN HEALTH, 2023, 26 (06) : S305 - S306
  • [6] Analysis of FGFR alterations from circulating tumor DNA (ctDNA) and Tissue in a phase II trial of erdafitinib in urothelial carcinoma (UC).
    Santiago-Walker, Ademi E.
    Moy, Christopher
    Cherkas, Yauheniya
    Loriot, Yohann
    Siefker-Radtke, Arlene O.
    Motley, Clifford
    Avadhani, Anjali Narayan
    OHagan, Anne
    De Porre, Peter
    Lorenzi, Matthew V.
    McCaffery, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [7] Circulating tumor (ct)-DNA alterations in advanced urothelial carcinoma: Association with outcomes and evolution with therapy.
    Grivas, Petros
    Nagy, Rebecca J.
    Pond, Gregory Russell
    Gupta, Sumati
    Wang, Jue
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [8] Circulating tumor DNA profile in pancreatic ductal adenocarcinoma (PDAC) and potential targeted therapy.
    Esposito, Francis
    Pesantez, David
    Angelats, Laura
    Indacochea, Alberto
    Martinez-Vidal, Joan
    Cochs, Alba
    Perez, Alexis
    Sole i Bentz, Pol
    Fernandez, Debora Moreno
    Faull, Iris
    Campillo, Mary Luz
    Garcia-Losada, Lidia
    Rodriguez, Angelica
    Vicente, Pilar
    Nogue, Miguel
    Victoria, Ivan
    Prat, Aleix
    Sauri, Tamara
    Garcia-Corbacho, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Efficacy, prognostic value of circulating tumor DNA (ctDNA) in ovarian cancer patients
    Heo, Jinho
    Kim, Yoo-Na
    Lee, Seung-Tae
    Lee, Jung-Yun
    Shin, Saeam
    Lee, Yong Jae
    Kim, Sang Wun
    Kim, Sunghoon
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S78 - S79
  • [10] Duration of Targeted Therapy in Advanced NSCLC (aNSCLC) with Drivers Identified by Circulating Tumor DNA (ctDNA) Analysis
    Baik, C.
    Patil, T.
    Kirtane, K.
    Santana-Davila, R.
    Rich, T.
    Espenschied, C.
    Weipert, C.
    Mach, S.
    Reckamp, K.
    Doebele, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S564 - S564
12345